3087 DOUTOR･NICHIRES Holdings Co.,Ltd. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

3087

TSE Prime

DOUTOR･NICHIRES Holdings Co.,Ltd.

2,794

JPY

-9

(-0.32%)

Jan 29, 3:30 pm JST

18.26

USD

Jan 29, 1:30 am EST

Result

PTS

outside of trading hours

2,795.9

Jan 29, 3:24 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Feb, 2022	109,363	-1,783	-1,478	1,221	27.6	26	Apr 14, 2022	J-GAAP
Feb, 2023	126,864	2,969	3,466	3,429	77.6	30	Apr 14, 2023	J-GAAP
Feb, 2024	140,625	7,322	7,701	5,491	124.9	40	Apr 12, 2024	J-GAAP
Feb, 2025	148,822	9,597	9,615	6,880	157.0	50	Apr 14, 2025	J-GAAP
Feb, 2026 Guidance	154,514	10,599	10,723	7,156	170.3	56	Jan 14, 2026	J-GAAP
YoY	+3.8%	+10.4%	+11.5%	+4.0%	+8.5%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Feb, 2021	Apr 14, 2020	ー	ー	ー	ー	34	J-GAAP
- - - - -	Jul 13, 2020	105,021	-193	-59	-4,147	－	J-GAAP
-	Oct 15, 2020	99,832	-4,592	-4,439	-7,995	－	J-GAAP
-	Apr 7, 2021	96,141	-4,319	-4,177	-10,979	24	J-GAAP
Results	Apr 14, 2021	96,141	-4,319	-4,177	-10,979	24	J-GAAP
Feb, 2022	Apr 14, 2021	Available in future release
	Apr 8, 2022
Results	Apr 14, 2022
Feb, 2023	Apr 14, 2022
	Jan 13, 2023
	Apr 7, 2023
Results	Apr 14, 2023
Feb, 2024	Apr 14, 2023
	Jul 14, 2023
	Oct 13, 2023
Results	Apr 12, 2024
Feb, 2025	Apr 12, 2024
	Jul 12, 2024
	Jan 14, 2025
Results	Apr 14, 2025
Feb, 2026	Apr 14, 2025	154,514	10,599	10,723	7,156	54	J-GAAP
	Jan 14, 2026	154,514	10,599	10,723	7,156	56	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2001	44,463	+12.0	Available in future release
Mar, 2002	52,319	+17.7
Mar, 2003	59,345	+13.4
Mar, 2004	61,713	+4.0
Mar, 2005	62,703	+1.6
Mar, 2006	66,312	+5.8
Mar, 2007	68,596	+3.4
Feb, 2008 Changed	101,314	－
Feb, 2009	103,967	+2.6
Feb, 2010	100,788	-3.1
Feb, 2011	105,011	+4.2
Feb, 2012	107,721	+2.6
Feb, 2013	107,825	+0.1
Feb, 2014	113,520	+5.3
Feb, 2015	120,020	+5.7
Feb, 2016	124,796	+4.0
Feb, 2017	126,927	+1.7
Feb, 2018	131,182	+3.4
Feb, 2019	129,216	-1.5
Feb, 2020	131,193	+1.5
Feb, 2021	96,141	-26.7
Feb, 2022	109,363	+13.8
Feb, 2023	126,864	+16.0
Feb, 2024	140,625	+10.8
Feb, 2025	148,822	+5.8
Feb, 2026 Guidance	154,514	+3.8	10,599	+10.4	10,723	+11.5	170.3	+8.5

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Feb, 2024	140,625	7,322	5.21	5.63	4.41	1.13	124.9
Feb, 2025	148,822	9,597	6.45	6.77	5.25	1.14	157.0
Feb, 2026 Guidance	154,514	10,599	6.86	6.92	5.27	1.14	170.3

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	148,822	10,514	10,675	6,880	157.0
Fiscal Year	Feb, 2025	Feb, 2017	Feb, 2017	Feb, 2025	Feb, 2025

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Sep - Feb, 2022	64,729	1,495	1,597	901	20.4	16	Apr 14, 2023	J-GAAP
Sep - Feb, 2023	69,664	3,261	3,418	1,856	42.2	20	Apr 12, 2024	J-GAAP
Sep - Feb, 2024	73,559	3,869	3,883	2,663	60.8	27	Apr 14, 2025	J-GAAP
Sep - Feb, 2025 Guidance	74,773	5,252	5,226	3,223	76.7	29	Jan 14, 2026	J-GAAP
YoY	+1.7%	+35.7%	+34.6%	+21.0%	+26.2%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Feb, 2023	2,969	-417	5,171	-5,588	-1,982	32,222	26.62	J-GAAP
Feb, 2024	7,322	6,891	11,795	-4,904	-3,373	35,796	28.01	J-GAAP
Feb, 2025	9,597	6,120	12,351	-6,231	-2,933	38,990	29.05	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Mar - Nov, 2023	106,234	5,762	6,063	4,972	113.0	78.7	Jan 12, 2024	J-GAAP
Mar - Nov, 2024	112,431	7,987	8,046	5,786	132.0	83.7	Jan 14, 2025	J-GAAP
Mar - Nov, 2025	119,737	7,999	8,336	5,754	135.4	77.7	Jan 14, 2026	J-GAAP
YoY	+6.5%	+0.2%	+3.6%	-0.6%	+2.6%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Dec - Feb, 2023	34,391	1,560	1,638	519	11.8	4.5	Apr 12, 2024	J-GAAP
Mar - May, 2024	36,906	2,981	3,100	2,379	54.3	8.1	Jul 12, 2024	J-GAAP
Jun - Aug, 2024	38,357	2,747	2,632	1,838	41.9	7.2	Oct 15, 2024	J-GAAP
Sep - Nov, 2024	37,168	2,259	2,314	1,569	35.8	6.1	Jan 14, 2025	J-GAAP
Dec - Feb, 2024	36,391	1,610	1,569	1,094	25.0	4.4	Apr 14, 2025	J-GAAP
Mar - May, 2025	39,315	2,787	2,850	2,074	47.8	7.1	Jul 11, 2025	J-GAAP
Jun - Aug, 2025	40,426	2,560	2,647	1,859	43.5	6.3	Oct 14, 2025	J-GAAP
Sep - Nov, 2025	39,996	2,652	2,839	1,821	42.9	6.6	Jan 14, 2026	J-GAAP
YoY	+7.6%	+17.4%	+22.7%	+16.1%	+19.7%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Dec - Feb, 2020	24,682	-22.1	Available in future release
Mar - May, 2021	26,541	+40.4
Jun - Aug, 2021	27,198	+7.2
Sep - Nov, 2021	28,167	+3.6
Dec - Feb, 2021	27,457	+11.2
Mar - May, 2022	30,540	+15.1
Jun - Aug, 2022	31,595	+16.2
Sep - Nov, 2022	32,324	+14.8
Dec - Feb, 2022	32,405	+18.0
Mar - May, 2023	35,176	+15.2
Jun - Aug, 2023	35,785	+13.3
Sep - Nov, 2023	35,273	+9.1
Dec - Feb, 2023	34,391	+6.1
Mar - May, 2024	36,906	+4.9
Jun - Aug, 2024	38,357	+7.2
Sep - Nov, 2024	37,168	+5.4
Dec - Feb, 2024	36,391	+5.8
Mar - May, 2025	39,315	+6.5
Jun - Aug, 2025	40,426	+5.4
Sep - Nov, 2025	39,996	+7.6	2,652	+17.4	2,839	+22.7	42.9	+19.8

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	40,426	3,207	3,192	2,379	54.3
Fiscal Year	Aug, 2025	May, 2017	May, 2017	May, 2024	May, 2024

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Feb, 2023	2,171.33	79.3	121,036	96,014	80,983	0.02	Apr 14, 2023	J-GAAP
Feb, 2024	2,262.89	77.6	127,788	99,155	84,891	0.02	Apr 12, 2024	J-GAAP
Feb, 2025	2,372.09	77.5	134,232	104,002	89,887	0.02	Apr 14, 2025	J-GAAP
Mar - Nov, 2025	ー	76.1	135,901	103,424	93,323	0.02	Jan 14, 2026	J-GAAP

DOUTOR･NICHIRES Holdings Co.,Ltd.(3087) Financial Results